GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » FCF Yield %

Kiadis Pharma NV (LTS:0RBP) FCF Yield % : -13.09 (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kiadis Pharma NV's Trailing 12-Month Free Cash Flow is €0.00 Mil, and Market Cap is €220.08 Mil. Therefore, Kiadis Pharma NV's FCF Yield % for today is -13.09%.

The historical rank and industry rank for Kiadis Pharma NV's FCF Yield % or its related term are showing as below:

LTS:0RBP' s FCF Yield % Range Over the Past 10 Years
Min: -13.09   Med: 0   Max: 0
Current: -13.09


LTS:0RBP's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -14.53 vs LTS:0RBP: -13.09

Kiadis Pharma NV's FCF Margin % for the quarter that ended in Dec. 2020 was -22.79%.


Kiadis Pharma NV FCF Yield % Historical Data

The historical data trend for Kiadis Pharma NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV FCF Yield % Chart

Kiadis Pharma NV Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -12.46 -11.55 -13.39 -71.65 -12.25

Kiadis Pharma NV Semi-Annual Data
Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15.29 -20.73 -80.10 -75.20 -3.74

Competitive Comparison of Kiadis Pharma NV's FCF Yield %

For the Biotechnology subindustry, Kiadis Pharma NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kiadis Pharma NV's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiadis Pharma NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kiadis Pharma NV's FCF Yield % falls into.



Kiadis Pharma NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kiadis Pharma NV's FCF Yield % for the fiscal year that ended in Dec. 2020 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-26.12 / 213.231965
=-12.25%

Kiadis Pharma NV's annualized FCF Yield % for the quarter that ended in Dec. 2020 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.988 * 2 / 213.231965
=-3.74%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kiadis Pharma NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Kiadis Pharma NV FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kiadis Pharma NV (LTS:0RBP) Business Description

Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (LTS:0RBP) Headlines

No Headlines